Legend Biotech (LEGN) Capital Expenditures Growth (1y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -142.37% |
| Jun 30, 2025 | -169.79% |
| Mar 31, 2025 | 67.93% |
| Dec 31, 2024 | -27.89% |
| Sep 30, 2024 | 61.60% |
| Jun 30, 2024 | 43.84% |
| Mar 31, 2024 | -46.07% |
| Dec 31, 2023 | 271.18% |
| Sep 30, 2023 | -108.57% |
| Jun 30, 2023 | -1,990.68% |
| Mar 31, 2023 | 64.73% |
| Dec 31, 2022 | 50.41% |
| Sep 30, 2022 | 77.55% |
| Jun 30, 2022 | 102.38% |
| Mar 31, 2022 | 21.35% |
| Dec 31, 2021 | -60.73% |
| Sep 30, 2021 | -61.82% |